Initiating peanut oral immunotherapy in peanut-allergic children under age four may be more effective: long term study

The majority of young children treated with peanut immunotherapy achieved desensitization after two and a half years of treatment, and one in five remained in remission 26 weeks after treatment ended, according to a randomized controlled trial published in The Lancet.

source https://medicalxpress.com/news/2022-01-peanut-oral-immunotherapy-peanut-allergic-children.html